AFM26 is a Novel, Highly Potent BCMA/CD16A-directed Bispecific Antibody for High Affinity NK-cell Engagement in Multiple Myeloma.Thorsten Gantke, Uwe Reusch,Christian Kellner,Kristina Ellwanger,Ivica Fucek,Michael Weichel,Anne Kerber,Matthias Peipp,Martin TrederJOURNAL OF CLINICAL ONCOLOGY（2017）引用 12|浏览33暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
